Author Search Results

Kim L. O'Neill

}}

'''Kim L. O'Neill''' is the developer of a monoclonal antibody that allows for the accurate, cheap and easy detection of cancer.

O'Neill has a B.Sc. degree from New University of Ulster and a Ph.D. from the University of Ulster. He is a full professor of microbiology at Brigham Young University. In 1998 research by O'Neill suggested a link between caffeine and the formation of some cancers. O'Neill has served as associate director of BYU's cancer research center.

O'Neill is also a convert to the Church of Jesus Christ of Latter-day Saints, having joined the church in Ireland. Provided by Wikipedia

1

Thymidine Kinase 1 Upregulation Is an Early Event in Breast Tumor Formation

by Melissa M. Alegre, Richard A. Robison, Kim L. O'Neill
Published 2012-01-01

Get full text

Article
2

The expansion of targetable biomarkers for CAR T cell therapy

by Michelle H. Townsend, Gajendra Shrestha, Richard A. Robison, Kim L. O’Neill
Published 2018-07-01

Get full text

Article
3

Thymidine kinase 1 through the ages: a comprehensive review

by Eliza E. Bitter, Michelle H. Townsend, Rachel Erickson, Carolyn Allen, Kim L. O’Neill
Published 2020-11-01

Get full text

Article
4

Potential new biomarkers for endometrial cancer

by Michelle H. Townsend, Zac E. Ence, Abigail M. Felsted, Alyssa C. Parker, Stephen R. Piccolo, Richard A. Robison, Kim L. O’Neill
Published 2019-01-01

Get full text

Article
5

Cytotoxicity of Atriplex confertifolia

by Christopher J. Capua, Nick P. Hopson, C. Malcolm M. Stewart, G. Robert Johnston, Kim L. O'Neill, G. Bruce Schaalje, Christopher M. Lee, Gary M. Booth
Published 2010-01-01

Get full text

Article
6

Evaluation of the upregulation and surface expression of hypoxanthine guanine phosphoribosyltransferase in acute lymphoblastic leukemia and Burkitt’s B cell lymphoma

by Michelle H. Townsend, Zac E. Ence, Taylor P. Cox, John E. Lattin, Weston Burrup, Michael K. Boyer, Stephen R. Piccolo, Richard A. Robison, Kim L. O’Neill
Published 2020-08-01

Get full text

Article
7

Novel monoclonal antibodies against thymidine kinase 1 and their potential use for the immunotargeting of lung, breast and colon cancer cells

by Edwin J. Velazquez, Taylor D. Brindley, Gajendra Shrestha, Eliza E. Bitter, Jordan D. Cress, Michelle H. Townsend, Bradford K. Berges, Richard A. Robison, K. Scott Weber, Kim L. O’Neill
Published 2020-04-01

Get full text

Article
8

Correction to: Membrane expression of thymidine kinase 1 and potential clinical relevance in lung, breast, and colorectal malignancies

by Evita G. Weagel, Weston Burrup, Roman Kovtun, Edwin J. Velazquez, Abigail M. Felsted, Michelle H. Townsend, Zachary E. Ence, Erica Suh, Stephen R. Piccolo, K. Scott Weber, Richard A. Robison, Kim L. O’Neill
Published 2019-02-01

Get full text

Article
9

Membrane expression of thymidine kinase 1 and potential clinical relevance in lung, breast, and colorectal malignancies

by Evita G. Weagel, Weston Burrup, Roman Kovtun, Edwin J. Velazquez, Abigail M. Felsted, Michelle H. Townsend, Zachary E. Ence, Erica Suh, Stephen R. Piccolo, K. Scott Weber, Richard A. Robison, Kim L. O’Neill
Published 2018-09-01

Get full text

Article
10

A Quadruplex Real-Time PCR Assay for the Rapid Detection and Differentiation of the Most Relevant Members of the B. pseudomallei Complex: B. mallei, B. pseudomallei, and B. thailan...

by Chinn-Woan Lowe, Benjamin A Satterfield, Daniel B Nelson, Joseph D Thiriot, Michael J Heder, Jordon K March, David S Drake, Cynthia S Lew, Annette J Bunnell, Emily S Moore, Kim L O'Neill, Richard A Robison
Published 2016-01-01

Get full text

Article